These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19023984)

  • 1. Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80.
    Kurakhmaeva KB; Voronina TA; Kapica IG; Kreuter J; Nerobkova LN; Seredenin SB; Balabanian VY; Alyautdin RN
    Bull Exp Biol Med; 2008 Feb; 145(2):259-62. PubMed ID: 19023984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Eur J Pharm Biopharm; 2008 Sep; 70(1):75-84. PubMed ID: 18472255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Alyautdin RN; Petrov VE; Langer K; Berthold A; Kharkevich DA; Kreuter J
    Pharm Res; 1997 Mar; 14(3):325-8. PubMed ID: 9098875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Gao K; Jiang X
    Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns.
    Göppert TM; Müller RH
    J Drug Target; 2005 Apr; 13(3):179-87. PubMed ID: 16036306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
    Alyautdin RN; Tezikov EB; Ramge P; Kharkevich DA; Begley DJ; Kreuter J
    J Microencapsul; 1998; 15(1):67-74. PubMed ID: 9463808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparkinsonian properties of a nerve growth factor dipeptide mimetic GK-2 in in vivo experiments.
    Povarnina PY; Gudasheva TA; Vorontsova ON; Bondarenko NA; Seredenin SB
    Bull Exp Biol Med; 2011 Oct; 151(6):690-3. PubMed ID: 22485209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
    Rempe R; Cramer S; Hüwel S; Galla HJ
    Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles.
    Kreuter J; Ramge P; Petrov V; Hamm S; Gelperina SE; Engelhardt B; Alyautdin R; von Briesen H; Begley DJ
    Pharm Res; 2003 Mar; 20(3):409-16. PubMed ID: 12669961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity.
    Olivier JC; Fenart L; Chauvet R; Pariat C; Cecchelli R; Couet W
    Pharm Res; 1999 Dec; 16(12):1836-42. PubMed ID: 10644071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism.
    da Rocha Lindner G; Bonfanti Santos D; Colle D; Gasnhar Moreira EL; Daniel Prediger R; Farina M; Khalil NM; Mara Mainardes R
    Nanomedicine (Lond); 2015; 10(7):1127-38. PubMed ID: 25929569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles.
    Tian XH; Lin XN; Wei F; Feng W; Huang ZC; Wang P; Ren L; Diao Y
    Int J Nanomedicine; 2011; 6():445-52. PubMed ID: 21445277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier].
    Zhao YM; Xia AX; Wei YH; Ruan YP; Li FZ
    Yao Xue Xue Bao; 2010 Oct; 45(10):1312-6. PubMed ID: 21348312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of apolipoproteins on dalargin transport across the blood-brain barrier.
    Shamenkov DA; Petrov VE; Alyautdin RN
    Bull Exp Biol Med; 2006 Dec; 142(6):703-6. PubMed ID: 17603675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
    Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
    J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The delivery of loperamide to the brain by using polybutyl cyanoacrylate nanoparticles].
    Aliautdin RN; Petrov VE; Langer K; Berthold A; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 1998; 61(1):17-20. PubMed ID: 9575405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
    Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
    ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.